These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

294 related articles for article (PubMed ID: 32044725)

  • 1. Novel Engineered Programmable Systems for ADAR-Mediated RNA Editing.
    Aquino-Jarquin G
    Mol Ther Nucleic Acids; 2020 Mar; 19():1065-1072. PubMed ID: 32044725
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Programmable RNA editing by recruiting endogenous ADAR using engineered RNAs.
    Qu L; Yi Z; Zhu S; Wang C; Cao Z; Zhou Z; Yuan P; Yu Y; Tian F; Liu Z; Bao Y; Zhao Y; Wei W
    Nat Biotechnol; 2019 Sep; 37(9):1059-1069. PubMed ID: 31308540
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Programmable RNA editing with endogenous ADAR enzymes - a feasible option for the treatment of inherited retinal disease?
    Bellingrath JS; McClements ME; Fischer MD; MacLaren RE
    Front Mol Neurosci; 2023; 16():1092913. PubMed ID: 37293541
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Precise RNA editing by recruiting endogenous ADARs with antisense oligonucleotides.
    Merkle T; Merz S; Reautschnig P; Blaha A; Li Q; Vogel P; Wettengel J; Li JB; Stafforst T
    Nat Biotechnol; 2019 Feb; 37(2):133-138. PubMed ID: 30692694
    [TBL] [Abstract][Full Text] [Related]  

  • 5. RNA-Guided Adenosine Deaminases: Advances and Challenges for Therapeutic RNA Editing.
    Chen G; Katrekar D; Mali P
    Biochemistry; 2019 Apr; 58(15):1947-1957. PubMed ID: 30943016
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mechanisms and implications of ADAR-mediated RNA editing in cancer.
    Wang C; Zou J; Ma X; Wang E; Peng G
    Cancer Lett; 2017 Dec; 411():27-34. PubMed ID: 28974449
    [TBL] [Abstract][Full Text] [Related]  

  • 7. To edit or not to edit: regulation of ADAR editing specificity and efficiency.
    Deffit SN; Hundley HA
    Wiley Interdiscip Rev RNA; 2016; 7(1):113-27. PubMed ID: 26612708
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Genome editing technologies: CRISPR, LEAPER, RESTORE, ARCUT, SATI, and RESCUE.
    Görücü Yilmaz S
    EXCLI J; 2021; 20():19-45. PubMed ID: 33510590
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Adenosine-to-inosine RNA editing and human disease.
    Slotkin W; Nishikura K
    Genome Med; 2013; 5(11):105. PubMed ID: 24289319
    [TBL] [Abstract][Full Text] [Related]  

  • 10. New Frontiers for Site-Directed RNA Editing: Harnessing Endogenous ADARs.
    Merkle T; Stafforst T
    Methods Mol Biol; 2021; 2181():331-349. PubMed ID: 32729089
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Engineered circular ADAR-recruiting RNAs increase the efficiency and fidelity of RNA editing in vitro and in vivo.
    Yi Z; Qu L; Tang H; Liu Z; Liu Y; Tian F; Wang C; Zhang X; Feng Z; Yu Y; Yuan P; Yi Z; Zhao Y; Wei W
    Nat Biotechnol; 2022 Jun; 40(6):946-955. PubMed ID: 35145313
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In vivo RNA editing of point mutations via RNA-guided adenosine deaminases.
    Katrekar D; Chen G; Meluzzi D; Ganesh A; Worlikar A; Shih YR; Varghese S; Mali P
    Nat Methods; 2019 Mar; 16(3):239-242. PubMed ID: 30737497
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Efficient in vitro and in vivo RNA editing via recruitment of endogenous ADARs using circular guide RNAs.
    Katrekar D; Yen J; Xiang Y; Saha A; Meluzzi D; Savva Y; Mali P
    Nat Biotechnol; 2022 Jun; 40(6):938-945. PubMed ID: 35145312
    [TBL] [Abstract][Full Text] [Related]  

  • 14. CLUSTER guide RNAs enable precise and efficient RNA editing with endogenous ADAR enzymes in vivo.
    Reautschnig P; Wahn N; Wettengel J; Schulz AE; Latifi N; Vogel P; Kang TW; Pfeiffer LS; Zarges C; Naumann U; Zender L; Li JB; Stafforst T
    Nat Biotechnol; 2022 May; 40(5):759-768. PubMed ID: 34980913
    [TBL] [Abstract][Full Text] [Related]  

  • 15. ADAR RNA editing below the backbone.
    Keegan L; Khan A; Vukic D; O'Connell M
    RNA; 2017 Sep; 23(9):1317-1328. PubMed ID: 28559490
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Short-Chain Guide RNA for Site-Directed A-to-I RNA Editing.
    Nose K; Hidaka K; Yano T; Tomita Y; Fukuda M
    Nucleic Acid Ther; 2021 Feb; 31(1):58-67. PubMed ID: 33170095
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Positive correlation between ADAR expression and its targets suggests a complex regulation mediated by RNA editing in the human brain.
    Liscovitch N; Bazak L; Levanon EY; Chechik G
    RNA Biol; 2014; 11(11):1447-56. PubMed ID: 25692240
    [TBL] [Abstract][Full Text] [Related]  

  • 18. ADAR RNA editing in innate immune response phasing, in circadian clocks and in sleep.
    Sinigaglia K; Wiatrek D; Khan A; Michalik D; Sambrani N; Sedmík J; Vukić D; O'Connell MA; Keegan LP
    Biochim Biophys Acta Gene Regul Mech; 2019 Mar; 1862(3):356-369. PubMed ID: 30391332
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Rewriting the transcriptome: adenosine-to-inosine RNA editing by ADARs.
    Walkley CR; Li JB
    Genome Biol; 2017 Oct; 18(1):205. PubMed ID: 29084589
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Harnessing ADAR-Mediated Site-Specific RNA Editing in Immune-Related Disease: Prediction and Therapeutic Implications.
    Weng S; Yang X; Yu N; Wang PC; Xiong S; Ruan H
    Int J Mol Sci; 2023 Dec; 25(1):. PubMed ID: 38203521
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.